BLECH ISAAC
Transactions
50
Companies
13
Filings
13
CIK
0000905536
Recent Transactions
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Conversion
- Conversion
Series E Convertible Preferred Stock
2018-04-16$5000.00/sh+103.7→ 103.7 total - Award
- Award
Series E Convertible Preferred Stock
2018-04-16$5000.00/sh+2.25→ 2.25 total - Conversion
- Award
- Award
- Award
- Award
- Award
- Purchase
- Purchase
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
Convertible Promissary Note (right to buy)
2015-11-13$173333.28/sh+231,111→ 231,111 total - Award
Convertible Promissary Note (right to buy)
2015-11-13$34000.00/sh+45,333→ 45,333 total - Disposition to Issuer
- Award
Companies
13- $ATRX
Adhera Therapeutics, Inc.
Director
Aevi Genomic Medicine, LLC
10% Owner
Aridis Pharmaceuticals, Inc.
Director
- $AVTX
Avalo Therapeutics, Inc.
Director
- $CRVO
CervoMed Inc.
10% Owner
CONTRAFECT Corp
Director
GreenHouse Holdings, Inc.
10% Owner
- $NSPR
InspireMD, Inc.
Director
- $PDSB
PDS Biotechnology Corp
Director
PROELITE, INC.
10% Owner
root9B Holdings, Inc.
10% Owner
SPENDSMART NETWORKS, INC.
Director, 10% Owner, Vice Chairman
- $XFOR
X4 Pharmaceuticals, Inc
Director
Recent Filings
13- 4/A
BLECH ISAAC
Apr 2, 2019
- 4
BLECH ISAAC
Mar 18, 2019
- 4
BLECH ISAAC
Mar 18, 2019
- 4
BLECH ISAAC
Mar 14, 2019
- 4
BLECH ISAAC
Jan 2, 2019
- 4
BLECH ISAAC
Oct 1, 2018
- 4
BLECH ISAAC
Aug 15, 2018
- 4
BLECH ISAAC
Jul 2, 2018
- 4
BLECH ISAAC
Jun 21, 2018
- 4
BLECH ISAAC
May 17, 2018
- 4
BLECH ISAAC
Apr 18, 2018
- 4
BLECH ISAAC
Apr 4, 2018
- 4
BLECH ISAAC
Jan 5, 2018
Address
75 ROCKEFELLER PLAZA, 29TH FLOOR
NEW YORK, NY, 10019